Tweetnope...im not sure about that one either..it contains H5N1 DNA and is derived from chicken embryo...
Flu Mist is a live cold-adapted trivalent nasally administered vaccine, which is currently being recommended for individuals between the age of 5 and 49 years. According to the 2005 Physicians Desk Reference (PDR), the probability of acquiring a transmitted vaccine virus following close contact with a single FluMist inoculee was estimated to be 2.4% (95% CI: 0.13-4.6) [31]. Because of the possible transmission of this vaccine’s viruses, vaccine recipients are advised to avoid close contact with immuno-compromised individuals for at least 21 days. Additionally, persons with conditions such as human immunodeficiency virus infection, malignancy, leukaemia, or lymphoma, and patients who may be immunosuppressed or have altered or compromised immune status as a consequence of treatment with systemic corticosteroids, alkylating drugs, antimetabolites, radiation, or other immunosuppressive therapies, may be at significant risk if exposed within 21 days to a FluMist vaccine inoculee. Other individuals who might be at high risk if exposed within 21 days to FluMist inoculees, include, but are not limited to, adults and children with chronic disorders of the cardiovascular and pulmonary systems, including asthma (which up to 25% of today’s children seem to have); pregnant women; and adults and children who required regular medical follow-up or hospitalization during the preceding year because of chronic metabolic diseases (including diabetes), renal dysfunction, or hemoglobinopathies. Additionally, because FluMist contains live influenza viruses, there is the possibility with the widespread use of FluMist, that an individual might have a second concurrent viral infection with another influenza strain (such as the avian bird flu), with the possibility that the live viruses from the FluMist recombine/re-assort with the second viral infection to produce a “super virus.” It is obvious from the extensive list of persons who might be at risk if exposed to a FluMist vaccine recipient within 21 days of vaccination, along with potential ability of the live influenza viruses within FluMist to recombine/re-assort with other viruses, that the continued use of FluMist presents a significant potential danger to the health and well-being of a wide segment of the population. This raises major concerns about the wisdom and ethics of recommending the use of FluMist for use in the general population.
so i'll take my chances on just dealing with the flu...